Prevention of heart failure
- 1 September 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 17 (5) , 512-517
- https://doi.org/10.1097/00001573-200209000-00011
Abstract
Heart failure carries a sizeable health burden. Efforts to prevent this condition are not generally well studied. Most of the interventions that have demonstrated benefit address cardiac risk factors such as hypertension and hyperlipidemia. The results of the HOPE study have recently expanded the indications for angiotensin converting enzyme inhibitors in the prevention of heart failure. Once heart failure occurs, a variety of interventions can prevent recurrent episodes of congestion. Biventricular pacing, left ventricular assist devices, and disease-specific management clinics join more standard medical therapies such as angiotensin converting enzyme inhibitors, beta-blockers, diuretics, digoxin, and spironolactone in improving outcomes for patients with this disorder.Keywords
This publication has 27 references indexed in Scilit:
- Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor RamiprilCirculation, 2001
- Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunctionPublished by Elsevier ,2001
- Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast CancerJournal of Clinical Oncology, 2001
- Implications of discontinuation of doxazosin arm of ALLHATThe Lancet, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Preventing the cardiotoxicity of anthracyclines by dexrazoxaneBMJ, 1999
- Heart failure: a medical hydraThe Lancet, 1998
- The effects of simvastatin on the incidence of heart failure in patients with coronary heart diseaseJournal of Cardiac Failure, 1997
- Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research GroupJAMA, 1997
- Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysisJAMA, 1997